Literature DB >> 20209341

Current resistance status to temephos in Aedes aegypti from different regions of Argentina.

G Albrieu Llinás1, E Seccacini, C N Gardenal, S Licastro.   

Abstract

In Argentina, more than 25,000 cases of dengue were reported in the summer of 2009, even in provinces where the disease was formerly absent. We analysed the susceptibility levels to the larvicide temephos in seven populations of Aedes aegypti, the primary vector of dengue, collected during summer 2007/2008, using the susceptible Rockefeller strain as a control. Although no control failures were observed during the experiment, a majority of the lethal concentration and resistance ratio values indicate an incipient resistance. An integrative program to monitor the resistance of Ae. aegypti to insecticides is needed in the country.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20209341     DOI: 10.1590/s0074-02762010000100019

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  16 in total

1.  Differential transcription profiles in Aedes aegypti detoxification genes after temephos selection.

Authors:  K Saavedra-Rodriguez; C Strode; A E Flores; S Garcia-Luna; G Reyes-Solis; H Ranson; J Hemingway; W C Black
Journal:  Insect Mol Biol       Date:  2013-12-03       Impact factor: 3.585

2.  Larvicidal and pupicidal activities of ecbolin A and ecbolin B isolated from Ecbolium viride (Forssk.) Alston against Culex quinquefasciatus Say (Diptera: Culicidae).

Authors:  Kalaimaran Francina Cecilia; Ramalingam Ravindhran; Munusamy Rajiv Gandhi; Appadurai Daniel Reegan; Kedike Balakrishna; Savarimuthu Ignacimuthu
Journal:  Parasitol Res       Date:  2014-07-17       Impact factor: 2.289

3.  Larvicidal and Pupicidal Activities of Alizarin Isolated from Roots of Rubia cordifolia Against Culex quinquefasciatus Say and Aedes aegypti (L.) (Diptera: Culicidae).

Authors:  M R Gandhi; A D Reegan; P Ganesan; K Sivasankaran; M G Paulraj; K Balakrishna; S Ignacimuthu; N A Al-Dhabi
Journal:  Neotrop Entomol       Date:  2016-03-23       Impact factor: 1.434

4.  Issues related to recent dengue vaccine development.

Authors:  Eiji Konishi
Journal:  Trop Med Health       Date:  2011-08-06

5.  Insecticide susceptibility of Aedes aegypti and Aedes albopictus in Central Africa.

Authors:  Basile Kamgang; Sébastien Marcombe; Fabrice Chandre; Elysée Nchoutpouen; Philippe Nwane; Josiane Etang; Vincent Corbel; Christophe Paupy
Journal:  Parasit Vectors       Date:  2011-05-15       Impact factor: 3.876

6.  Novel, meso-substituted cationic porphyrin molecule for photo-mediated larval control of the dengue vector Aedes aegypti.

Authors:  Leonardo Lucantoni; Michela Magaraggia; Giulio Lupidi; Robert Kossivi Ouedraogo; Olimpia Coppellotti; Fulvio Esposito; Clara Fabris; Giulio Jori; Annette Habluetzel
Journal:  PLoS Negl Trop Dis       Date:  2011-12-20

7.  Physiological and morphological aspects of Aedes aegypti developing larvae: effects of the chitin synthesis inhibitor novaluron.

Authors:  Luana C Farnesi; José M Brito; Jutta G Linss; Marcelo Pelajo-Machado; Denise Valle; Gustavo L Rezende
Journal:  PLoS One       Date:  2012-01-24       Impact factor: 3.240

8.  Pinpointing P450s associated with pyrethroid metabolism in the dengue vector, Aedes aegypti: developing new tools to combat insecticide resistance.

Authors:  Bradley J Stevenson; Patricia Pignatelli; Dimitra Nikou; Mark J I Paine
Journal:  PLoS Negl Trop Dis       Date:  2012-03-27

9.  QTL mapping of genome regions controlling temephos resistance in larvae of the mosquito Aedes aegypti.

Authors:  Guadalupe Del Carmen Reyes-Solis; Karla Saavedra-Rodriguez; Adriana Flores Suarez; William C Black
Journal:  PLoS Negl Trop Dis       Date:  2014-10-16

10.  Temephos resistance in Aedes aegypti in Colombia compromises dengue vector control.

Authors:  Nelson Grisales; Rodolphe Poupardin; Santiago Gomez; Idalyd Fonseca-Gonzalez; Hilary Ranson; Audrey Lenhart
Journal:  PLoS Negl Trop Dis       Date:  2013-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.